Updated August 16, 2026

Rinvoq Savings Card: What the $0 Copay Program Actually Covers

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: AbbVie doesn't run one Rinvoq savings program — it runs three, under overlapping names. This guide separates them, walks through what each one actually pays for, and flags the copay accumulator issue that can quietly undo your $0 copay mid-year.
Quick Answer

The RINVOQ Complete Savings Card can bring your copay to $0 if you have commercial (private or employer) insurance and an FDA-approved indication, up to a $14,000 annual maximum benefit. But that's only one of three AbbVie programs sharing the "RINVOQ Complete" name. If your insurance denied coverage and you're appealing, the separate Bridge Program can supply Rinvoq free for up to 24 months — but only if you're 63 or younger. If you're uninsured or underinsured, myAbbVie Assist is the income-based path to free medication instead. None of the three work with Medicare, Medicaid, TRICARE, or VA coverage.

Bottom line: which program is "yours" depends entirely on your insurance status right now, not just whether you have a prescription.

$0

Possible monthly cost with
commercial insurance + card

$14,000/yr

Maximum annual
Savings Card benefit

$7,090.41

List price (WAC) per 30-day
supply, as of Jan. 6, 2026

Key Takeaways

  • AbbVie runs three separate Rinvoq financial programs — the Savings Card, the Bridge Program, and myAbbVie Assist — and mixing them up is the most common reason people apply for the wrong one.
  • The Bridge Program (free Rinvoq during a coverage appeal) has an age cap of 63; the standard Savings Card does not.
  • The $14,000 annual cap is a ceiling on the card's benefit, not a guarantee that your out-of-pocket cost stays at $0 all year — copay accumulator and maximizer programs can undercut it.
  • myAbbVie Assist isn't strictly for the uninsured. AbbVie says it can weigh out-of-pocket burden even for some insured applicants.
  • There's no generic upadacitinib, so a manufacturer program (or a modest pharmacy discount card) is essentially your only lever on price.

Search "Rinvoq savings card" and you'll land on a dozen pages that all say roughly the same thing: pay as little as $0 a month, up to $14,000 a year. That's true, but it's also incomplete in a way that causes real problems. AbbVie doesn't operate one program. It operates three, all branded under "RINVOQ Complete," and which one actually applies to you depends on a detail most articles skip entirely: whether your insurance has approved, denied, or simply doesn't exist yet.

Rinvoq (upadacitinib) has been on the market since the FDA approved it for rheumatoid arthritis on August 16, 2019 — seven years ago today, as it happens. In that time AbbVie has added indications and, with them, more moving parts to its financial support system. Get the wrong program, and you'll either waste weeks on an application that was never going to fit your situation, or miss a benefit that would have covered your prescription completely.

Three Different Programs, One Confusing Name

Here's the distinction most guides collapse into one paragraph. It shouldn't be one paragraph — the eligibility rules, and what you actually receive, are different for each.

The three AbbVie financial programs for Rinvoq
Program Who It's For What You Get
RINVOQ Complete Savings Card Commercially insured patients with an active, covered prescription As little as $0/month, up to $14,000/year
RINVOQ Complete Bridge Program Commercially insured patients, age 63 or younger, whose coverage was denied and who are appealing Free medication for up to 24 months
myAbbVie Assist Uninsured, underinsured, or otherwise unable to afford Rinvoq, income-qualified Free medication, roughly a year at a time

Why the confusion happens: all three are marketed under the same "RINVOQ Complete" umbrella and share a phone number, 1-800-2RINVOQ. If you call describing yourself as "trying to get help affording Rinvoq" without mentioning whether your insurance approved, denied, or doesn't exist, the specialist has to ask a follow-up question before routing you correctly. Knowing your own status before you call saves a step.

Eligibility: Which Program Is Actually Yours

Match your situation to the row below. If more than one seems to fit, use the one further down the list first — the Bridge Program and myAbbVie Assist are designed for people the standard card can't help.

Your Situation Program Key Requirement
Commercial insurance, Rinvoq approved and covered Savings Card Enroll before or at first fill
Commercial insurance, PA denied, appeal filed Bridge Program Age 63 or younger; resubmit appeal proof every 180 days
Uninsured or underinsured, income-qualified myAbbVie Assist Income and insurance documentation
Insured, but out-of-pocket costs still unaffordable Possibly myAbbVie Assist AbbVie reviews insurance + income + OOP costs together
Medicare, Medicaid, TRICARE, or VA coverage None of the above See the Medicare section below instead

What the Numbers Actually Mean

The list price (Wholesale Acquisition Cost, or WAC) for a 30-day supply of Rinvoq was $7,090.41 as of January 6, 2026, according to AbbVie's own cost page. That works out to roughly $85,000 a year if you were somehow paying full list price out of pocket with no insurance and no assistance at all — which almost nobody actually does, since WAC is a benchmark figure, not what pharmacies typically charge after rebates and negotiated discounts.

That context matters for understanding the $14,000 cap. It sounds generous, and for most commercially insured patients it is — the card is offsetting a copay or coinsurance amount your plan sets, not the full list price, so $14,000 usually covers the entire year with room to spare. Where it gets tight is with high-deductible health plans early in the plan year, when your full negotiated cost (not just a copay) may be applied toward your deductible before the plan starts sharing costs. In that scenario the card can burn through a larger share of its annual limit in the first few months.

The Copay Accumulator Trap

This is the part almost no consumer-facing guide explains clearly, and it's the single most useful thing to understand before you assume "$0 a month" means $0 a month for the whole year.

Some health plans use what's called a copay accumulator adjustment program or a copay maximizer program. In plain terms: your plan lets AbbVie's card pay toward your prescription at the pharmacy, but doesn't count that payment toward your annual deductible or out-of-pocket maximum. From your plan's perspective, you haven't paid anything toward your deductible yet, even though your prescription showed a $0 balance every month.

The result shows up later in the year. Once the Savings Card's $14,000 limit is exhausted, or once your plan year resets, you may suddenly owe your full deductible on Rinvoq or another drug, because none of the manufacturer's contribution ever applied toward it. AbbVie's own program terms acknowledge this directly: the patient is responsible for any amount owed after the card is applied, and AbbVie asks patients who discover their plan runs an accumulator or maximizer program to call and discuss alternative options. AbbVie also states it monitors for maximizer-program usage and can discontinue the assistance if it's detected.

What to actually do about it: before you assume the card guarantees $0 all year, call your insurance plan's member services line and ask directly: "Does my plan have a copay accumulator adjustment or copay maximizer program?" It's a specific enough question that most representatives can answer it immediately, and knowing the answer in January is far more useful than discovering it in September.

How to Enroll in the Savings Card

1

Confirm you have commercial insurance

Employer-sponsored or privately purchased plans qualify. Medicare, Medicaid, TRICARE, and VA coverage do not, regardless of whether you also carry supplemental commercial coverage for something else.

2

Enroll online or by phone

Sign up through AbbVie's savings program page at rinvoq.com, or call 1-800-2RINVOQ (1-800-274-6867) to enroll with an insurance specialist. Doing this when your prescription is written, rather than waiting until you're at the pharmacy counter, avoids a first-fill delay.

3

Access your card through the app

Download the RINVOQ Complete app (search "RINVOQ Complete," or text APP to 33101) to pull up your card at the pharmacy and track refills.

4

If the pharmacy can't process it directly, request a rebate

Some specialty pharmacies have trouble running the card at checkout. If that happens, pay out of pocket, keep the receipt, and submit it through the app, online, or by mail for the Complete Rebate program to reimburse you.

How to Use the Bridge Program if You're Denied

This program exists specifically for the gap between "my insurance said no" and "my insurance said yes on appeal," and it's easy to miss because it isn't advertised as prominently as the Savings Card.

1

Get a documented denial and start an appeal

You need a valid Rinvoq prescription for an FDA-approved indication, a prior authorization denial on file, and a confirmation that an appeal has been filed. See our Prior Authorization Guides for how the appeal process typically works.

2

Confirm you're 63 or younger

This program specifically caps eligibility at age 63 — likely tied to the approaching transition to Medicare at 65, since Medicare patients can't use any AbbVie copay program. The standard Savings Card doesn't have this age limit.

3

Enroll through your prescriber's office

Ask your prescriber's office to coordinate enrollment through CompletePro.com or by calling 1-800-2RINVOQ. AbbVie can then ship medication to you at no cost while the appeal is active.

4

Resubmit proof of your appeal every 180 days

This is the step people miss. Staying enrolled requires you (or your prescriber's office) to keep submitting evidence the appeal is still active every 180 days. The free supply ends after 24 months total, or as soon as your insurer approves coverage, whichever happens first.

How to Apply to myAbbVie Assist

1

Check whether you qualify, even with some insurance

myAbbVie Assist is usually described as being "for the uninsured," but AbbVie's own eligibility language is broader: for insured applicants, it says it reviews financial need based on a combination of insurance coverage, household income, and out-of-pocket medical costs — not insurance status alone. If your coverage exists but your real out-of-pocket burden is high, it's worth applying rather than assuming you're automatically excluded.

2

Gather income and insurance documentation

Recent pay stubs or a tax return, plus documentation of your current insurance status (or lack of it).

3

Complete the application with your prescriber

The application requires both a patient section and a prescriber section confirming your diagnosis and prescribed use.

5

Plan to reapply roughly annually

Approved patients typically receive medication at no cost for about a year before needing to resubmit updated documentation.

Decision Tree: Which Path Fits You

Do you have commercial insurance?

Employer or privately purchased — not Medicare/Medicaid/TRICARE/VA

Yes, Commercially Insured

Is Rinvoq approved and covered?

Or was it denied and are you appealing?

Approved: Savings Card. Denied + appealing + age ≤63: Bridge Program

Different programs, different requirements

No / Uninsured

On Medicare or Medicaid?

This changes your realistic options

No: apply to myAbbVie Assist. Medicare: try Extra Help first

Extra Help denial can support a later myAbbVie Assist application

Insured but still can't afford it?

Apply to myAbbVie Assist anyway — insurance status alone isn't disqualifying

Card vs. Patient Assistance: Trade-Offs

Savings Card — Pros

  • Works immediately once enrolled, often at your very next fill
  • No income documentation required
  • Up to $14,000/year, which covers most commercially insured patients' full annual copay
  • Accessible instantly through the RINVOQ Complete app

myAbbVie Assist — Trade-Offs

  • Requires income documentation and prescriber sign-off
  • Approval takes real time, not instant like the card
  • Roughly annual reapplication with fresh paperwork
  • Not available if your commercial plan requires it as a coverage condition

Common Mistakes to Avoid

  • □ Assuming "Rinvoq savings card" is a single program instead of three separate ones with different eligibility rules.
  • □ Applying for the Bridge Program without confirming you're 63 or younger first.
  • □ Never asking your insurer whether your plan runs a copay accumulator or maximizer program.
  • □ Ruling out myAbbVie Assist just because you technically have insurance.
  • □ Letting a Bridge Program appeal go 180 days without resubmitting proof it's still active.
  • □ Waiting until the pharmacy counter to enroll instead of doing it when the prescription is written.
  • □ Assuming any government insurance, active or supplemental, keeps you eligible for the manufacturer card.

The single most expensive mistake is the accumulator one — not because it's common, but because it's invisible until the bill shows up. If you're on a high-deductible plan, ask the accumulator question before your first fill, not after your fourth.

Real Examples

Example 1 — Standard enrollment: A patient with employer-sponsored insurance gets Rinvoq approved for psoriatic arthritis on the first prior authorization request. They enroll in the Savings Card the same day their prescriber sends the prescription, and their first fill at a specialty pharmacy costs $0.

Example 2 — Denied and appealing: A 54-year-old with active Crohn's disease is denied coverage after their insurer requires proof of a failed TNF blocker first. Their prescriber files an appeal and enrolls them in the Bridge Program the same week; AbbVie ships Rinvoq at no cost while the appeal is pending, and the prescriber's office resubmits appeal documentation at the 180-day mark to keep the free supply active.

Example 3 — Uninsured, income-qualified: A patient between jobs with no active coverage applies to myAbbVie Assist for atopic dermatitis. After documentation review, they're approved for roughly a year of free medication and told to reapply as the approval period nears its end.

Example 4 — The accumulator surprise: A patient with a high-deductible plan uses the Savings Card every month and pays $0 at the counter. In September, after the plan year's deductible resets, they discover none of the card's contribution ever counted toward it — their plan runs an accumulator program — and they suddenly owe the full deductible amount. They call 1-800-2RINVOQ to ask about alternative support once this is discovered.

What Rinvoq Treats, and Why That Matters for Eligibility

Every program above requires the prescription to be for an FDA-approved indication, so it's worth knowing what that currently covers. As of 2026, Rinvoq is approved for moderately to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis, refractory moderate-to-severe atopic dermatitis, giant cell arteritis, and moderate-to-severe ulcerative colitis and Crohn's disease. That last pair got broader in October 2025, when the FDA updated the indication to allow use after any approved systemic therapy, not strictly a failed TNF blocker, when a TNF blocker isn't clinically appropriate.

Rinvoq carries a boxed warning shared across the JAK inhibitor class, covering serious infections, mortality, malignancies, major adverse cardiovascular events, and thrombosis. That's a clinical conversation for you and your prescriber, not a savings-program detail, but it explains why every AbbVie financial program insists on documentation that the prescription is genuinely for an approved use, rather than being a rubber-stamp discount available to anyone with a script.

If You Have Medicare or Medicaid

None of the three AbbVie programs above are available to you, regardless of activity status, because federal anti-kickback rules bar manufacturer copay assistance for government insurance beneficiaries. Your realistic options look different:

Situation Option
Low-income Medicare Part D enrollee Extra Help (LIS) — in 2026, no more than $12.65 per covered branded prescription
Any Medicare Part D enrollee 2026 Part D $2,100 annual out-of-pocket cap, with monthly payment plan option
Denied Extra Help, still low-income A denial letter can support a myAbbVie Assist application
Medicaid enrollee Coverage and prior authorization rules vary by state Medicaid program

If you have Medicare Part A or B for medical care but pay for prescriptions purely through separate commercial drug coverage, not a Part D plan, ask an AbbVie insurance specialist directly whether you might still qualify. Eligibility in that specific overlap depends on plan structure, and it's worth a phone call rather than assuming the standard "no government insurance" rule automatically excludes you.


Bottom Line

The Rinvoq Complete Savings Card really can get your copay to $0, but treating it as one simple coupon is where people go wrong. Whether you're looking at the Savings Card, the Bridge Program, or myAbbVie Assist depends on one question: is your insurance approving, denying, or absent right now? Answer that first, and the right program — and the right phone call to 1-800-2RINVOQ — becomes obvious.

If you have commercial insurance and an approved prescription, enroll in the Savings Card before your first fill. If you're mid-appeal, ask specifically about the Bridge Program by name. And if you're on a high-deductible plan, make the accumulator phone call before you assume $0 means $0 for the year.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using AbbVie's current RINVOQ Complete program materials and terms, FDA prescribing and indication information, Medicare Part D and Extra Help program guidance, and federal poverty level and anti-kickback program rules governing manufacturer copay assistance.

Every article undergoes editorial review for accuracy, readability, and consistency before publication, and we update pages promptly when a manufacturer program's terms or a drug's approved indications change.


References

  1. AbbVie Inc. RINVOQ Complete Savings Card, Bridge Program, and Complete Rebate program terms and eligibility materials.
  2. AbbVie Inc. myAbbVie Assist patient assistance program eligibility materials.
  3. U.S. Food and Drug Administration (FDA). RINVOQ (upadacitinib) prescribing information and approved indications, including the October 2025 ulcerative colitis and Crohn's disease indication update.
  4. Centers for Medicare & Medicaid Services (CMS). Medicare Part D benefit design, Extra Help (Low-Income Subsidy), and 2026 out-of-pocket cap guidance.
  5. NeedyMeds. Independent patient assistance and discount program directory.

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, patient assistance programs, pharmacy benefits and medication access. Our editorial team combines pricing research with practical guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based pricing and program research
  • Editorial review before publication
  • Regular updates when a program's status or eligibility rules change
  • Clear distinction between educational content and medical or financial advice

Related Resources

Frequently Asked Questions

It can genuinely be $0, but that figure is a ceiling, not a guarantee. It applies only to commercially insured patients, up to a $14,000 annual maximum benefit. If your plan runs a copay accumulator or maximizer program, you may still hit an unexpected bill later in the year even while technically enrolled.

The Savings Card lowers your copay on an active, covered prescription. The Bridge Program is a separate benefit for patients whose insurance has denied coverage and who are actively appealing — it provides free Rinvoq for up to 24 months while the appeal is pending, and is limited to commercially insured patients age 63 or younger.

Yes, through the Bridge Program rather than the standard Savings Card. You need a documented denial, an appeal on file, and commercial insurance. You must resubmit proof of your ongoing appeal every 180 days to stay enrolled, and the free supply ends after 24 months or once coverage is approved, whichever comes first.

Once the annual maximum is used up, you're responsible for whatever your plan still charges. AbbVie's terms explicitly state the patient is personally responsible for any remaining cost, and that it cannot be covered by a health plan or another assistance program. Most patients never reach the cap since it only offsets your copay, not the full list price.

It can. Accumulator adjustment programs let the insurer accept AbbVie's payment at the pharmacy without counting that amount toward your deductible or out-of-pocket maximum. That means you can use the card every month and still owe your full deductible later, since none of the card's money applied toward it. AbbVie asks patients to report known accumulator or maximizer programs by calling their insurance specialist line.

Possibly, though it's not guaranteed. AbbVie states that for insured applicants, it reviews financial need based on a combination of insurance coverage, household income, and out-of-pocket medical costs, not insurance status alone. It's worth applying if your out-of-pocket burden is genuinely high, even with coverage in place, but patients whose insurer requires a myAbbVie Assist application as a condition of covering the drug are not eligible.

No. Rinvoq (upadacitinib) currently has no generic equivalent, so the manufacturer's own programs, or a pharmacy discount card applied to the brand price, are the only levers available for lowering the cost. This is different from some other AbbVie products where biosimilar alternatives already exist.

Not through the manufacturer copay card, which federal anti-kickback rules bar for anyone on government insurance. Medicare patients should look at Part D Extra Help, which limits what you pay per covered brand-name prescription, and the 2026 Part D annual out-of-pocket cap. Low-income Medicare beneficiaries denied Extra Help may then qualify for myAbbVie Assist.

You can enroll online through AbbVie's savings program page or by calling 1-800-2RINVOQ to speak with an insurance specialist. Once enrolled, your card is accessible through the RINVOQ Complete app. Enrolling at the time your prescription is written, rather than waiting until the pharmacy counter, avoids delays on your first fill.

You can still recover the savings after the fact. AbbVie's Complete Rebate program lets you submit your pharmacy receipt online, through the app, or by mailing a paper form, and reimburses your eligible out-of-pocket cost rather than applying the discount at checkout.

Contact Refill Relay